Epileptic  ||| S:0 E:10 ||| JJ
motor  ||| S:10 E:16 ||| NN
behaviors  ||| S:16 E:26 ||| NN
during  ||| S:26 E:33 ||| IN
sleep ||| S:33 E:38 ||| NN
:  ||| S:38 E:40 ||| :
anatomo-electro-clinical  ||| S:40 E:65 ||| JJ
features  ||| S:65 E:74 ||| NNS
Sleep-related  ||| S:74 E:88 ||| JJ
complex  ||| S:88 E:96 ||| JJ
motor  ||| S:96 E:102 ||| NN
seizures  ||| S:102 E:111 ||| NNS
have  ||| S:111 E:116 ||| VBP
long  ||| S:116 E:121 ||| RB
been  ||| S:121 E:126 ||| VBN
considered  ||| S:126 E:137 ||| VBN
pathognomonic  ||| S:137 E:151 ||| JJ
features  ||| S:151 E:160 ||| NNS
of  ||| S:160 E:163 ||| IN
Nocturnal  ||| S:163 E:173 ||| NNP
Frontal  ||| S:173 E:181 ||| NNP
Lobe  ||| S:181 E:186 ||| NNP
Epilepsy  ||| S:186 E:195 ||| NNP
( ||| S:195 E:196 ||| -LRB-
NFLE ||| S:196 E:200 ||| NNP
) ||| S:200 E:201 ||| -RRB-
.  ||| S:201 E:203 ||| .
In  ||| S:203 E:206 ||| IN
recent  ||| S:206 E:213 ||| JJ
years ||| S:213 E:218 ||| NNS
,  ||| S:218 E:220 ||| ,
these  ||| S:220 E:226 ||| DT
manifestations  ||| S:226 E:241 ||| NNS
have  ||| S:241 E:246 ||| VBP
also  ||| S:246 E:251 ||| RB
been  ||| S:251 E:256 ||| VBN
reported  ||| S:256 E:265 ||| VBN
to  ||| S:265 E:268 ||| TO
have  ||| S:268 E:273 ||| VB
a  ||| S:273 E:275 ||| DT
temporal  ||| S:275 E:284 ||| NN
or  ||| S:284 E:287 ||| CC
insular  ||| S:287 E:295 ||| JJ
origin ||| S:295 E:301 ||| NN
.  ||| S:301 E:303 ||| .
We  ||| S:303 E:306 ||| PRP
describe  ||| S:306 E:315 ||| VBP
40  ||| S:315 E:318 ||| CD
drug-resistant  ||| S:318 E:333 ||| JJ
epileptic  ||| S:333 E:343 ||| JJ
patients  ||| S:343 E:352 ||| NNS
with  ||| S:352 E:357 ||| IN
complex  ||| S:357 E:365 ||| JJ
motor  ||| S:365 E:371 ||| NN
seizures  ||| S:371 E:380 ||| NNS
during  ||| S:380 E:387 ||| IN
sleep ||| S:387 E:392 ||| NN
,  ||| S:392 E:394 ||| ,
submitted  ||| S:394 E:404 ||| VBN
to  ||| S:404 E:407 ||| TO
presurgical  ||| S:407 E:419 ||| VB
stereo-EEG  ||| S:419 E:430 ||| JJ
( ||| S:430 E:431 ||| -LRB-
SEEG ||| S:431 E:435 ||| NNP
)  ||| S:435 E:437 ||| -RRB-
evaluation  ||| S:437 E:448 ||| NN
and  ||| S:448 E:452 ||| CC
seizure-free  ||| S:452 E:465 ||| JJ
after  ||| S:465 E:471 ||| IN
surgical  ||| S:471 E:480 ||| JJ
resection  ||| S:480 E:490 ||| NN
of  ||| S:490 E:493 ||| IN
the  ||| S:493 E:497 ||| DT
epileptogenic  ||| S:497 E:511 ||| JJ
zone ||| S:511 E:515 ||| NN
.  ||| S:515 E:517 ||| .
In  ||| S:517 E:520 ||| IN
a  ||| S:520 E:522 ||| DT
significant  ||| S:522 E:534 ||| JJ
proportion  ||| S:534 E:545 ||| NN
( ||| S:545 E:546 ||| -LRB-
30 ||| S:546 E:548 ||| CD
% ||| S:548 E:549 ||| NN
)  ||| S:549 E:551 ||| -RRB-
of  ||| S:551 E:554 ||| IN
these  ||| S:554 E:560 ||| DT
patients ||| S:560 E:568 ||| NNS
,  ||| S:568 E:570 ||| ,
seizures  ||| S:570 E:579 ||| NNS
arose  ||| S:579 E:585 ||| VBD
from  ||| S:585 E:590 ||| IN
extra-frontal  ||| S:590 E:604 ||| JJ
regions ||| S:604 E:611 ||| NNS
,  ||| S:611 E:613 ||| ,
including  ||| S:613 E:623 ||| VBG
mainly  ||| S:623 E:630 ||| RB
the  ||| S:630 E:634 ||| DT
temporal  ||| S:634 E:643 ||| JJ
lobe  ||| S:643 E:648 ||| NN
and  ||| S:648 E:652 ||| CC
the  ||| S:652 E:656 ||| DT
insular  ||| S:656 E:664 ||| JJ
cortex ||| S:664 E:670 ||| NN
,  ||| S:670 E:672 ||| ,
but  ||| S:672 E:676 ||| CC
also  ||| S:676 E:681 ||| RB
the  ||| S:681 E:685 ||| DT
parietal  ||| S:685 E:694 ||| NN
and  ||| S:694 E:698 ||| CC
occipital  ||| S:698 E:708 ||| JJ
lobes ||| S:708 E:713 ||| NN
.  ||| S:713 E:715 ||| .
In  ||| S:715 E:718 ||| IN
patients  ||| S:718 E:727 ||| NNS
with  ||| S:727 E:732 ||| IN
extra-frontal  ||| S:732 E:746 ||| JJ
epilepsy ||| S:746 E:754 ||| NN
,  ||| S:754 E:756 ||| ,
when  ||| S:756 E:761 ||| WRB
complex  ||| S:761 E:769 ||| JJ
motor  ||| S:769 E:775 ||| NN
behaviors  ||| S:775 E:785 ||| NNS
appeared ||| S:785 E:793 ||| VBD
,  ||| S:793 E:795 ||| ,
SEEG  ||| S:795 E:800 ||| NNP
revealed  ||| S:800 E:809 ||| VBD
that  ||| S:809 E:814 ||| IN
the  ||| S:814 E:818 ||| DT
ictal  ||| S:818 E:824 ||| JJ
discharge  ||| S:824 E:834 ||| NN
involved  ||| S:834 E:843 ||| VBD
the  ||| S:843 E:847 ||| DT
cingulate  ||| S:847 E:857 ||| NN
and  ||| S:857 E:861 ||| CC
the  ||| S:861 E:865 ||| DT
frontal  ||| S:865 E:873 ||| JJ
regions ||| S:873 E:880 ||| NNS
.  ||| S:880 E:882 ||| .
Finally ||| S:882 E:889 ||| RB
,  ||| S:889 E:891 ||| ,
at  ||| S:891 E:894 ||| IN
histology ||| S:894 E:903 ||| NN
,  ||| S:903 E:905 ||| ,
Taylor ||| S:905 E:911 ||| NNP
's  ||| S:911 E:914 ||| POS
focal  ||| S:914 E:920 ||| JJ
cortical  ||| S:920 E:929 ||| JJ
dysplasia  ||| S:929 E:939 ||| NNS
( ||| S:939 E:940 ||| -LRB-
TFCD ||| S:940 E:944 ||| NNP
)  ||| S:944 E:946 ||| -RRB-
was  ||| S:946 E:950 ||| VBD
the  ||| S:950 E:954 ||| DT
most  ||| S:954 E:959 ||| RBS
common  ||| S:959 E:966 ||| JJ
finding  ||| S:966 E:974 ||| NN
( ||| S:974 E:975 ||| -LRB-
90 ||| S:975 E:977 ||| CD
%  ||| S:977 E:979 ||| NN
of  ||| S:979 E:982 ||| IN
patients ||| S:982 E:990 ||| NNS
) ||| S:990 E:991 ||| -RRB-
,  ||| S:991 E:993 ||| ,
independent  ||| S:993 E:1005 ||| JJ
of  ||| S:1005 E:1008 ||| IN
the  ||| S:1008 E:1012 ||| DT
site  ||| S:1012 E:1017 ||| NN
of  ||| S:1017 E:1020 ||| IN
seizure  ||| S:1020 E:1028 ||| NN
onset ||| S:1028 E:1033 ||| NN
.  ||| S:1033 E:1035 ||| .
As  ||| S:1035 E:1038 ||| RB
previously  ||| S:1038 E:1049 ||| RB
reported  ||| S:1049 E:1058 ||| VBN
by  ||| S:1058 E:1061 ||| IN
other  ||| S:1061 E:1067 ||| JJ
studies ||| S:1067 E:1074 ||| NNS
,  ||| S:1074 E:1076 ||| ,
this  ||| S:1076 E:1081 ||| DT
histologic  ||| S:1081 E:1092 ||| JJ
substrate  ||| S:1092 E:1102 ||| NN
may  ||| S:1102 E:1106 ||| MD
be  ||| S:1106 E:1109 ||| VB
a  ||| S:1109 E:1111 ||| DT
major  ||| S:1111 E:1117 ||| JJ
determinant  ||| S:1117 E:1129 ||| NN
of  ||| S:1129 E:1132 ||| IN
sleep-related  ||| S:1132 E:1146 ||| JJ
seizures  ||| S:1146 E:1155 ||| NNS
in  ||| S:1155 E:1158 ||| IN
drug-resistant  ||| S:1158 E:1173 ||| JJ
epileptic  ||| S:1173 E:1183 ||| JJ
patients ||| S:1183 E:1191 ||| NNS
.  ||| S:1191 E:1193 ||| .
